nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—Personality disorder—Carmustine—malignant glioma	0.028	0.0387	CcSEcCtD
Metoprolol—Altered state of consciousness—Temozolomide—malignant glioma	0.0253	0.0351	CcSEcCtD
Metoprolol—Cerebration impaired—Temozolomide—malignant glioma	0.0199	0.0275	CcSEcCtD
Metoprolol—Memory impairment—Temozolomide—malignant glioma	0.0149	0.0206	CcSEcCtD
Metoprolol—Disturbance in attention—Temozolomide—malignant glioma	0.0135	0.0187	CcSEcCtD
Metoprolol—Hearing impaired—Temozolomide—malignant glioma	0.0123	0.017	CcSEcCtD
Metoprolol—Musculoskeletal pain—Temozolomide—malignant glioma	0.0118	0.0164	CcSEcCtD
Metoprolol—Depressed level of consciousness—Carmustine—malignant glioma	0.0117	0.0162	CcSEcCtD
Metoprolol—Depressed level of consciousness—Temozolomide—malignant glioma	0.0113	0.0156	CcSEcCtD
Metoprolol—Coma—Carmustine—malignant glioma	0.0111	0.0153	CcSEcCtD
Metoprolol—Dry eye—Temozolomide—malignant glioma	0.0108	0.015	CcSEcCtD
Metoprolol—Mental disability—Carmustine—malignant glioma	0.0105	0.0145	CcSEcCtD
Metoprolol—Mental disability—Temozolomide—malignant glioma	0.0101	0.0141	CcSEcCtD
Metoprolol—Diabetes mellitus—Carmustine—malignant glioma	0.0101	0.014	CcSEcCtD
Metoprolol—Deafness—Temozolomide—malignant glioma	0.00949	0.0131	CcSEcCtD
Metoprolol—Amnesia—Carmustine—malignant glioma	0.00935	0.0129	CcSEcCtD
Metoprolol—Hot flush—Temozolomide—malignant glioma	0.00907	0.0126	CcSEcCtD
Metoprolol—Amnesia—Temozolomide—malignant glioma	0.00903	0.0125	CcSEcCtD
Metoprolol—Menopausal symptoms—Temozolomide—malignant glioma	0.00899	0.0125	CcSEcCtD
Metoprolol—Affect lability—Temozolomide—malignant glioma	0.00835	0.0116	CcSEcCtD
Metoprolol—Liver function test abnormal—Carmustine—malignant glioma	0.00811	0.0112	CcSEcCtD
Metoprolol—Mood swings—Temozolomide—malignant glioma	0.00804	0.0111	CcSEcCtD
Metoprolol—Breast disorder—Temozolomide—malignant glioma	0.00767	0.0106	CcSEcCtD
Metoprolol—Sweating increased—Temozolomide—malignant glioma	0.00715	0.0099	CcSEcCtD
Metoprolol—Pneumonia—Carmustine—malignant glioma	0.00681	0.00943	CcSEcCtD
Metoprolol—Erectile dysfunction—Temozolomide—malignant glioma	0.00676	0.00936	CcSEcCtD
Metoprolol—Depression—Carmustine—malignant glioma	0.00675	0.00935	CcSEcCtD
Metoprolol—Photosensitivity reaction—Temozolomide—malignant glioma	0.0067	0.00927	CcSEcCtD
Metoprolol—Weight increased—Temozolomide—malignant glioma	0.00668	0.00925	CcSEcCtD
Metoprolol—Pneumonia—Temozolomide—malignant glioma	0.00658	0.00911	CcSEcCtD
Metoprolol—Depression—Temozolomide—malignant glioma	0.00652	0.00903	CcSEcCtD
Metoprolol—Hepatobiliary disease—Temozolomide—malignant glioma	0.00619	0.00857	CcSEcCtD
Metoprolol—Chlorphenesin—BCHE—malignant glioma	0.00612	0.685	CrCbGaD
Metoprolol—Hallucination—Carmustine—malignant glioma	0.00605	0.00837	CcSEcCtD
Metoprolol—Oedema peripheral—Carmustine—malignant glioma	0.00599	0.00829	CcSEcCtD
Metoprolol—Connective tissue disorder—Carmustine—malignant glioma	0.00597	0.00827	CcSEcCtD
Metoprolol—Hepatitis—Temozolomide—malignant glioma	0.00587	0.00813	CcSEcCtD
Metoprolol—Visual impairment—Carmustine—malignant glioma	0.00586	0.00811	CcSEcCtD
Metoprolol—Hallucination—Temozolomide—malignant glioma	0.00584	0.00809	CcSEcCtD
Metoprolol—Oedema peripheral—Temozolomide—malignant glioma	0.00578	0.00801	CcSEcCtD
Metoprolol—Connective tissue disorder—Temozolomide—malignant glioma	0.00577	0.00799	CcSEcCtD
Metoprolol—Eye disorder—Carmustine—malignant glioma	0.00568	0.00786	CcSEcCtD
Metoprolol—Visual impairment—Temozolomide—malignant glioma	0.00566	0.00784	CcSEcCtD
Metoprolol—Eye disorder—Temozolomide—malignant glioma	0.00549	0.0076	CcSEcCtD
Metoprolol—Tinnitus—Temozolomide—malignant glioma	0.00547	0.00758	CcSEcCtD
Metoprolol—Cardiac disorder—Temozolomide—malignant glioma	0.00545	0.00755	CcSEcCtD
Metoprolol—Arrhythmia—Carmustine—malignant glioma	0.00543	0.00752	CcSEcCtD
Metoprolol—Alopecia—Carmustine—malignant glioma	0.00537	0.00744	CcSEcCtD
Metoprolol—Angiopathy—Temozolomide—malignant glioma	0.00533	0.00738	CcSEcCtD
Metoprolol—Mental disorder—Carmustine—malignant glioma	0.00532	0.00737	CcSEcCtD
Metoprolol—Immune system disorder—Temozolomide—malignant glioma	0.0053	0.00734	CcSEcCtD
Metoprolol—Mediastinal disorder—Temozolomide—malignant glioma	0.00529	0.00733	CcSEcCtD
Metoprolol—Alopecia—Temozolomide—malignant glioma	0.00519	0.00719	CcSEcCtD
Metoprolol—Mental disorder—Temozolomide—malignant glioma	0.00514	0.00712	CcSEcCtD
Metoprolol—Dysgeusia—Temozolomide—malignant glioma	0.00501	0.00693	CcSEcCtD
Metoprolol—Vision blurred—Carmustine—malignant glioma	0.00498	0.0069	CcSEcCtD
Metoprolol—Vision blurred—Temozolomide—malignant glioma	0.00482	0.00667	CcSEcCtD
Metoprolol—Leukopenia—Carmustine—malignant glioma	0.00473	0.00656	CcSEcCtD
Metoprolol—Vertigo—Temozolomide—malignant glioma	0.00459	0.00636	CcSEcCtD
Metoprolol—Leukopenia—Temozolomide—malignant glioma	0.00458	0.00634	CcSEcCtD
Metoprolol—Hypertension—Carmustine—malignant glioma	0.00457	0.00632	CcSEcCtD
Metoprolol—Palpitations—Temozolomide—malignant glioma	0.00452	0.00626	CcSEcCtD
Metoprolol—Chest pain—Carmustine—malignant glioma	0.0045	0.00624	CcSEcCtD
Metoprolol—Anxiety—Carmustine—malignant glioma	0.00449	0.00621	CcSEcCtD
Metoprolol—Hypertension—Temozolomide—malignant glioma	0.00441	0.00611	CcSEcCtD
Metoprolol—Confusional state—Carmustine—malignant glioma	0.00435	0.00603	CcSEcCtD
Metoprolol—Arthralgia—Temozolomide—malignant glioma	0.00435	0.00603	CcSEcCtD
Metoprolol—Anxiety—Temozolomide—malignant glioma	0.00434	0.00601	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00432	0.00598	CcSEcCtD
Metoprolol—Oedema—Carmustine—malignant glioma	0.00432	0.00598	CcSEcCtD
Metoprolol—Dry mouth—Temozolomide—malignant glioma	0.00426	0.00589	CcSEcCtD
Metoprolol—Thrombocytopenia—Carmustine—malignant glioma	0.00423	0.00585	CcSEcCtD
Metoprolol—Tachycardia—Carmustine—malignant glioma	0.00421	0.00583	CcSEcCtD
Metoprolol—Confusional state—Temozolomide—malignant glioma	0.00421	0.00583	CcSEcCtD
Metoprolol—Oedema—Temozolomide—malignant glioma	0.00417	0.00578	CcSEcCtD
Metoprolol—Nervous system disorder—Temozolomide—malignant glioma	0.00409	0.00567	CcSEcCtD
Metoprolol—Thrombocytopenia—Temozolomide—malignant glioma	0.00408	0.00566	CcSEcCtD
Metoprolol—Skin disorder—Temozolomide—malignant glioma	0.00405	0.00561	CcSEcCtD
Metoprolol—Hypotension—Carmustine—malignant glioma	0.00403	0.00559	CcSEcCtD
Metoprolol—Hyperhidrosis—Temozolomide—malignant glioma	0.00403	0.00558	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00393	0.00545	CcSEcCtD
Metoprolol—Insomnia—Carmustine—malignant glioma	0.0039	0.00541	CcSEcCtD
Metoprolol—Paraesthesia—Carmustine—malignant glioma	0.00388	0.00537	CcSEcCtD
Metoprolol—Dyspnoea—Carmustine—malignant glioma	0.00385	0.00533	CcSEcCtD
Metoprolol—Somnolence—Carmustine—malignant glioma	0.00384	0.00531	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0038	0.00526	CcSEcCtD
Metoprolol—Insomnia—Temozolomide—malignant glioma	0.00377	0.00523	CcSEcCtD
Metoprolol—Paraesthesia—Temozolomide—malignant glioma	0.00375	0.00519	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00373	0.00516	CcSEcCtD
Metoprolol—Dyspnoea—Temozolomide—malignant glioma	0.00372	0.00515	CcSEcCtD
Metoprolol—Somnolence—Temozolomide—malignant glioma	0.00371	0.00514	CcSEcCtD
Metoprolol—Pain—Carmustine—malignant glioma	0.00369	0.00511	CcSEcCtD
Metoprolol—Constipation—Carmustine—malignant glioma	0.00369	0.00511	CcSEcCtD
Metoprolol—Dyspepsia—Temozolomide—malignant glioma	0.00367	0.00509	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0036	0.00499	CcSEcCtD
Metoprolol—Fatigue—Temozolomide—malignant glioma	0.0036	0.00498	CcSEcCtD
Metoprolol—Pain—Temozolomide—malignant glioma	0.00357	0.00494	CcSEcCtD
Metoprolol—Constipation—Temozolomide—malignant glioma	0.00357	0.00494	CcSEcCtD
Metoprolol—Feeling abnormal—Carmustine—malignant glioma	0.00356	0.00493	CcSEcCtD
Metoprolol—Gastrointestinal pain—Carmustine—malignant glioma	0.00353	0.00489	CcSEcCtD
Metoprolol—Feeling abnormal—Temozolomide—malignant glioma	0.00344	0.00476	CcSEcCtD
Metoprolol—Body temperature increased—Carmustine—malignant glioma	0.00341	0.00473	CcSEcCtD
Metoprolol—Abdominal pain—Carmustine—malignant glioma	0.00341	0.00473	CcSEcCtD
Metoprolol—Gastrointestinal pain—Temozolomide—malignant glioma	0.00341	0.00472	CcSEcCtD
Metoprolol—Urticaria—Temozolomide—malignant glioma	0.00331	0.00459	CcSEcCtD
Metoprolol—Abdominal pain—Temozolomide—malignant glioma	0.0033	0.00457	CcSEcCtD
Metoprolol—Body temperature increased—Temozolomide—malignant glioma	0.0033	0.00457	CcSEcCtD
Metoprolol—Hypersensitivity—Carmustine—malignant glioma	0.00318	0.0044	CcSEcCtD
Metoprolol—Asthenia—Carmustine—malignant glioma	0.0031	0.00429	CcSEcCtD
Metoprolol—Hypersensitivity—Temozolomide—malignant glioma	0.00307	0.00426	CcSEcCtD
Metoprolol—Asthenia—Temozolomide—malignant glioma	0.00299	0.00414	CcSEcCtD
Metoprolol—Diarrhoea—Carmustine—malignant glioma	0.00295	0.00409	CcSEcCtD
Metoprolol—Pruritus—Temozolomide—malignant glioma	0.00295	0.00409	CcSEcCtD
Metoprolol—Dizziness—Carmustine—malignant glioma	0.00285	0.00395	CcSEcCtD
Metoprolol—Diarrhoea—Temozolomide—malignant glioma	0.00285	0.00395	CcSEcCtD
Metoprolol—Chlorphenesin—PTGS2—malignant glioma	0.00282	0.315	CrCbGaD
Metoprolol—Dizziness—Temozolomide—malignant glioma	0.00276	0.00382	CcSEcCtD
Metoprolol—Vomiting—Carmustine—malignant glioma	0.00274	0.0038	CcSEcCtD
Metoprolol—Rash—Carmustine—malignant glioma	0.00272	0.00377	CcSEcCtD
Metoprolol—Dermatitis—Carmustine—malignant glioma	0.00272	0.00377	CcSEcCtD
Metoprolol—Headache—Carmustine—malignant glioma	0.0027	0.00375	CcSEcCtD
Metoprolol—Vomiting—Temozolomide—malignant glioma	0.00265	0.00367	CcSEcCtD
Metoprolol—Rash—Temozolomide—malignant glioma	0.00263	0.00364	CcSEcCtD
Metoprolol—Dermatitis—Temozolomide—malignant glioma	0.00263	0.00364	CcSEcCtD
Metoprolol—Headache—Temozolomide—malignant glioma	0.00261	0.00362	CcSEcCtD
Metoprolol—Nausea—Carmustine—malignant glioma	0.00256	0.00355	CcSEcCtD
Metoprolol—Nausea—Temozolomide—malignant glioma	0.00248	0.00343	CcSEcCtD
Metoprolol—CYP2C19—Metabolism—IDH2—malignant glioma	0.00015	0.000558	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000147	0.000547	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—IDH2—malignant glioma	0.000147	0.000545	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—H3F3A—malignant glioma	0.000144	0.000536	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—F2—malignant glioma	0.000143	0.000533	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCR3—malignant glioma	0.000143	0.000531	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000142	0.000527	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000141	0.000525	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—H3F3A—malignant glioma	0.000141	0.000525	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.00014	0.000521	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—F2—malignant glioma	0.00014	0.000521	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCR3—malignant glioma	0.00014	0.00052	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—YWHAE—malignant glioma	0.000139	0.000517	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NTRK2—malignant glioma	0.000139	0.000517	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FLT1—malignant glioma	0.000138	0.000514	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—IDH2—malignant glioma	0.000138	0.000514	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000138	0.000513	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DUSP6—malignant glioma	0.000138	0.000512	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000137	0.00051	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—JAG1—malignant glioma	0.000136	0.000506	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—YWHAE—malignant glioma	0.000136	0.000505	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NTRK2—malignant glioma	0.000136	0.000505	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOTCH3—malignant glioma	0.000135	0.000504	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FLT1—malignant glioma	0.000135	0.000503	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000135	0.000503	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DUSP6—malignant glioma	0.000135	0.000501	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000134	0.000499	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FBXW7—malignant glioma	0.000133	0.000495	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—JAG1—malignant glioma	0.000133	0.000495	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	0.000133	0.000493	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000132	0.000492	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BDKRB2—malignant glioma	0.000131	0.000486	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FBXW7—malignant glioma	0.00013	0.000485	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—F2—malignant glioma	0.00013	0.000484	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.00013	0.000483	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—IDH1—malignant glioma	0.000129	0.00048	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	0.000128	0.000475	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—F2—malignant glioma	0.000127	0.000473	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—IDH1—malignant glioma	0.000126	0.000469	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000126	0.000468	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	0.000125	0.000466	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000125	0.000465	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SPHK1—malignant glioma	0.000125	0.000465	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	0.000125	0.000463	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	0.000123	0.000456	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTP1—malignant glioma	0.000123	0.000456	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2C18—malignant glioma	0.000122	0.000455	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	0.000122	0.000455	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SPHK1—malignant glioma	0.000122	0.000454	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	0.000122	0.000453	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	0.000122	0.000452	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000121	0.000448	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	0.00012	0.000445	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2C18—malignant glioma	0.00012	0.000444	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAT—malignant glioma	0.000119	0.000444	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KNG1—malignant glioma	0.000119	0.000442	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	0.000119	0.000442	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—IDH1—malignant glioma	0.000119	0.000442	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000118	0.000438	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KNG1—malignant glioma	0.000116	0.000432	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000115	0.000429	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000115	0.000427	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000115	0.000427	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT2—malignant glioma	0.000114	0.000423	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NTRK1—malignant glioma	0.000113	0.000421	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NCOR1—malignant glioma	0.000113	0.000419	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000113	0.000419	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT2—malignant glioma	0.000111	0.000414	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000111	0.000413	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NTRK1—malignant glioma	0.000111	0.000412	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	0.000109	0.000407	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	0.000107	0.000398	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP3—malignant glioma	0.000105	0.000392	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000105	0.000391	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000105	0.000391	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	0.000104	0.000388	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP3—malignant glioma	0.000103	0.000383	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000103	0.000382	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	0.000102	0.00038	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000102	0.000377	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTK2—malignant glioma	0.000101	0.000377	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	0.000101	0.000375	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HES1—malignant glioma	9.96e-05	0.00037	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTK2—malignant glioma	9.92e-05	0.000369	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTT1—malignant glioma	9.91e-05	0.000368	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NCOR1—malignant glioma	9.9e-05	0.000368	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	9.88e-05	0.000367	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—RAF1—malignant glioma	9.77e-05	0.000363	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HES1—malignant glioma	9.75e-05	0.000362	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NCOR1—malignant glioma	9.69e-05	0.00036	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTT1—malignant glioma	9.67e-05	0.000359	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—IL2—malignant glioma	9.65e-05	0.000359	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—RAF1—malignant glioma	9.56e-05	0.000355	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	9.54e-05	0.000355	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	9.49e-05	0.000353	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—IL2—malignant glioma	9.44e-05	0.000351	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.38e-05	0.000349	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	9.33e-05	0.000347	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS1—malignant glioma	9.28e-05	0.000345	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	9.28e-05	0.000345	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.25e-05	0.000344	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SPP1—malignant glioma	9.21e-05	0.000342	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAV1—malignant glioma	9.19e-05	0.000342	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	9.17e-05	0.000341	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTT1—malignant glioma	9.11e-05	0.000339	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS1—malignant glioma	9.06e-05	0.000337	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SPP1—malignant glioma	9.01e-05	0.000335	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	8.97e-05	0.000333	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL2—malignant glioma	8.76e-05	0.000326	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TERT—malignant glioma	8.73e-05	0.000324	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—BCHE—malignant glioma	8.63e-05	0.000321	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL2—malignant glioma	8.57e-05	0.000319	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TERT—malignant glioma	8.54e-05	0.000317	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS1—malignant glioma	8.54e-05	0.000317	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC5A5—malignant glioma	8.52e-05	0.000317	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDGFB—malignant glioma	8.52e-05	0.000317	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGFR1—malignant glioma	8.48e-05	0.000315	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—BCHE—malignant glioma	8.42e-05	0.000313	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CG—malignant glioma	8.37e-05	0.000311	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HIF1A—malignant glioma	8.35e-05	0.00031	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDGFB—malignant glioma	8.33e-05	0.00031	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC5A5—malignant glioma	8.32e-05	0.000309	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGFR1—malignant glioma	8.29e-05	0.000308	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HIF1A—malignant glioma	8.17e-05	0.000304	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—malignant glioma	8.08e-05	0.0003	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CAV1—malignant glioma	8.07e-05	0.0003	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.06e-05	0.0003	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.99e-05	0.000297	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KDR—malignant glioma	7.98e-05	0.000297	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—BCHE—malignant glioma	7.94e-05	0.000295	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CAV1—malignant glioma	7.9e-05	0.000294	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC5A5—malignant glioma	7.84e-05	0.000291	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KDR—malignant glioma	7.81e-05	0.00029	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—F2—malignant glioma	7.69e-05	0.000286	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FN1—malignant glioma	7.69e-05	0.000286	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.66e-05	0.000285	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BAD—malignant glioma	7.59e-05	0.000282	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	7.52e-05	0.00028	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FN1—malignant glioma	7.52e-05	0.000279	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—F2—malignant glioma	7.52e-05	0.000279	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BAD—malignant glioma	7.43e-05	0.000276	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CD80—malignant glioma	7.37e-05	0.000274	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CD—malignant glioma	7.36e-05	0.000274	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	7.36e-05	0.000273	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APC—malignant glioma	7.35e-05	0.000273	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	7.35e-05	0.000273	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGF—malignant glioma	7.27e-05	0.00027	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	7.23e-05	0.000269	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CD80—malignant glioma	7.21e-05	0.000268	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	7.19e-05	0.000267	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APC—malignant glioma	7.19e-05	0.000267	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGF—malignant glioma	7.11e-05	0.000264	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	7.07e-05	0.000263	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.97e-05	0.000259	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BRAF—malignant glioma	6.91e-05	0.000257	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTP1—malignant glioma	6.87e-05	0.000255	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BRAF—malignant glioma	6.76e-05	0.000251	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT2—malignant glioma	6.73e-05	0.00025	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTP1—malignant glioma	6.7e-05	0.000249	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	6.7e-05	0.000249	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAT—malignant glioma	6.68e-05	0.000248	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT2—malignant glioma	6.58e-05	0.000245	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	6.55e-05	0.000244	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAT—malignant glioma	6.52e-05	0.000242	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	6.47e-05	0.00024	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CB—malignant glioma	6.41e-05	0.000238	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	6.4e-05	0.000238	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—malignant glioma	6.35e-05	0.000236	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	6.33e-05	0.000235	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	6.32e-05	0.000235	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTP1—malignant glioma	6.31e-05	0.000235	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NCOR1—malignant glioma	6.31e-05	0.000235	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	6.26e-05	0.000233	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	6.19e-05	0.00023	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF2—malignant glioma	6.19e-05	0.00023	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NCOR1—malignant glioma	6.16e-05	0.000229	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAT—malignant glioma	6.14e-05	0.000228	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF2—malignant glioma	6.06e-05	0.000225	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	5.82e-05	0.000216	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NCOR1—malignant glioma	5.8e-05	0.000216	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MDM2—malignant glioma	5.79e-05	0.000215	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RAF1—malignant glioma	5.77e-05	0.000215	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	5.71e-05	0.000212	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	5.69e-05	0.000211	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MDM2—malignant glioma	5.67e-05	0.000211	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RAF1—malignant glioma	5.65e-05	0.00021	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	5.64e-05	0.000209	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	5.59e-05	0.000208	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTEN—malignant glioma	5.54e-05	0.000206	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	5.51e-05	0.000205	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	5.42e-05	0.000201	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	5.3e-05	0.000197	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	5.23e-05	0.000194	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—malignant glioma	5.18e-05	0.000193	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL2—malignant glioma	5.18e-05	0.000192	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAV1—malignant glioma	5.14e-05	0.000191	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	5.12e-05	0.00019	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—malignant glioma	5.07e-05	0.000188	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL2—malignant glioma	5.06e-05	0.000188	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAV1—malignant glioma	5.02e-05	0.000187	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.91e-05	0.000183	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—malignant glioma	4.9e-05	0.000182	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTEN—malignant glioma	4.87e-05	0.000181	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—malignant glioma	4.79e-05	0.000178	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTEN—malignant glioma	4.76e-05	0.000177	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	4.75e-05	0.000177	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAV1—malignant glioma	4.73e-05	0.000176	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.68e-05	0.000174	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	4.65e-05	0.000173	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CG—malignant glioma	4.57e-05	0.00017	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—malignant glioma	4.52e-05	0.000168	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—malignant glioma	4.41e-05	0.000164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	4.4e-05	0.000164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—malignant glioma	4.36e-05	0.000162	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.31e-05	0.00016	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	4.3e-05	0.00016	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—malignant glioma	4.26e-05	0.000158	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—malignant glioma	4.16e-05	0.000155	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.12e-05	0.000153	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MYC—malignant glioma	4.05e-05	0.00015	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CD—malignant glioma	4.02e-05	0.000149	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MYC—malignant glioma	3.96e-05	0.000147	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGFR—malignant glioma	3.96e-05	0.000147	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CA—malignant glioma	3.91e-05	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGFR—malignant glioma	3.87e-05	0.000144	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.79e-05	0.000141	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KRAS—malignant glioma	3.74e-05	0.000139	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KRAS—malignant glioma	3.66e-05	0.000136	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.59e-05	0.000133	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—malignant glioma	3.56e-05	0.000132	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CB—malignant glioma	3.5e-05	0.00013	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—malignant glioma	3.47e-05	0.000129	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	3.44e-05	0.000128	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	3.36e-05	0.000125	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—malignant glioma	3.32e-05	0.000124	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.3e-05	0.000123	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—malignant glioma	3.27e-05	0.000122	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—malignant glioma	3.25e-05	0.000121	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—malignant glioma	3.19e-05	0.000119	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTEN—malignant glioma	3.1e-05	0.000115	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTEN—malignant glioma	3.03e-05	0.000113	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTEN—malignant glioma	2.85e-05	0.000106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—malignant glioma	2.81e-05	0.000104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—malignant glioma	2.75e-05	0.000102	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.19e-05	8.13e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CA—malignant glioma	2.14e-05	7.94e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.01e-05	7.48e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—malignant glioma	1.79e-05	6.65e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—malignant glioma	1.74e-05	6.49e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—malignant glioma	1.64e-05	6.11e-05	CbGpPWpGaD
